Why the study?
Does a monoclonal antibody to GM-CSF improve left ventricular function and reduce tissue macrophages in a rat coronary artery ligation model of myocardial infarction?
Does a monoclonal antibody to GM-CSF improve left ventricular function and reduce tissue macrophages in a rat coronary artery ligation model of myocardial infarction?
Answers are grounded in this paper and cite their sources.
Inhibition of GM-CSF improves left ventricular function and reduces macrophage infiltration in a rat model of myocardial infarction, suggesting a potential therapeutic target for post-MI heart failure.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kellar et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: